{"entity":{"id":"norgine","kind":"company","name":"Norgine","aka":["Norgine B.V.","Norgine Ltd","Norgine Pharmaceuticals"],"tldr":"Norgine is a European specialty pharmaceutical company, founded in 1906 and based in Amsterdam, best known in cancer care for bowel preparations used before colonoscopy and for in-licensed cancer medicines.","summary":"Norgine is a privately held European pharmaceutical company headquartered in Amsterdam with a history going back to 1906. It markets gastroenterology and supportive-care products, including bowel-cleansing preparations used ahead of colonoscopy and colorectal cancer screening, and licenses oncology medicines for Europe and Australia. It appears on ClinicalTrials.gov as lead sponsor of phase 3 trials in cancer settings.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.norgine.com"},{"label":"ClinicalTrials.gov: trials led by Norgine","url":"https://clinicaltrials.gov/search?lead=Norgine"},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q97041850"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["colorectal"],"sections":[],"technologies":["colorectal-screening"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Amsterdam","country":"NL","companyType":"pharma","website":"https://www.norgine.com","founded":1906,"stage":"private-large","investors":[],"funding":[]},"route":"/companies/norgine/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"technology":[{"id":"colorectal-screening","kind":"technology","name":"Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood)","route":"/technologies/colorectal-screening/"}]}}